-
1
-
-
16844363404
-
Tissue plasminogen activator in central nervous system physiology and pathology
-
Melchor JP, Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 2005; 93:655-60.
-
(2005)
Thromb Haemost
, vol.93
, pp. 655-660
-
-
Melchor, J.P.1
Strickland, S.2
-
2
-
-
84857642949
-
The toxic ab oligomer and alzheimer's disease: An emperor in need of clothes
-
Benilova I, Karran E, Strooper BD. The toxic Ab oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 2012;15:349-57.
-
(2012)
Nat Neurosci
, vol.15
, pp. 349-357
-
-
Benilova, I.1
Karran, E.2
Strooper, B.D.3
-
3
-
-
0028928084
-
In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues
-
Kingston IB, Castro MJ, Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat Med 1995;1:138-42.
-
(1995)
Nat Med
, vol.1
, pp. 138-142
-
-
Kingston, I.B.1
Castro, M.J.2
Anderson, S.3
-
4
-
-
0031079734
-
Amyloid b peptides stimulate tissue-type plasminogen activator but not recombinant prouroki-nase
-
Wnendt S, Wetzels I, Günzler WA. Amyloid b peptides stimulate tissue-type plasminogen activator but not recombinant prouroki-nase. Thromb Res 1997;85:217-24.
-
(1997)
Thromb Res
, vol.85
, pp. 217-224
-
-
Wnendt, S.1
Wetzels, I.2
Günzler, W.A.3
-
5
-
-
0037195269
-
Gebbink MFBG. Tissue-type plasminogen activator is a multiligand cross-b structure receptor
-
Kranenburg O, Bouma B, Kroon-Batenburg LMJ, Reijerkerk A, Wu Y-P, Voest EE, Gebbink MFBG. Tissue-type plasminogen activator is a multiligand cross-b structure receptor. Curr Biol 2002;12: 1833-9.
-
(2002)
Curr Biol
, vol.12
, pp. 1833-1839
-
-
Kranenburg, O.1
Bouma, B.2
Lmj, K.3
Reijerkerk, A.4
Wu, Y.-P.5
Voest, E.E.6
-
6
-
-
0033621048
-
Plasmin cleavage of the amyloid b-protein: Alteration of secondary structure and stimulation of tissue plasminogen activator activity
-
Van Nostrand WE, Porter M. Plasmin cleavage of the amyloid b-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity. Biochemistry 1999;38:11570-6.
-
(1999)
Biochemistry
, vol.38
, pp. 11570-11576
-
-
Van Nostrand, W.E.1
Porter, M.2
-
7
-
-
18544410708
-
The plasmin system is induced by and degrades amyloid-b aggregates
-
Tucker HM, Kihiko M, Caldwell JN, Wright S, Kawarabayashi T, Price D, Walker D, et al. The plasmin system is induced by and degrades amyloid-b aggregates. J Neurosci 2000;20:3937-46.
-
(2000)
J Neurosci
, vol.20
, pp. 3937-3946
-
-
Tucker, H.M.1
Kihiko, M.2
Caldwell, J.N.3
Wright, S.4
Kawarabayashi, T.5
Price, D.6
Walker, D.7
-
8
-
-
0033788789
-
Tissue plasminogen activator requires plasminogen to modulate amyloid-b neurotoxicity and deposition
-
Tucker HM, Kihiko-Ehmann M, Wright S, Rydel RE, Estus S. Tissue plasminogen activator requires plasminogen to modulate amyloid-b neurotoxicity and deposition. J Neurochem 2000;75: 2172-7.
-
(2000)
J Neurochem
, vol.75
, pp. 2172-2177
-
-
Tucker, H.M.1
Kihiko-Ehmann, M.2
Wright, S.3
Rydel, R.E.4
Estus, S.5
-
9
-
-
34547451637
-
Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease
-
Lee J-Y, Kweon H-S, Cho E, Lee J-Y, Byun H-R, Kim DH, Kim Y-H, et al. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease. Neurosci Lett 2007;423:82-7.
-
(2007)
Neurosci Lett
, vol.423
, pp. 82-87
-
-
Lee, J.-Y.1
Kweon, H.-S.2
Cho, E.3
Lee, J.-Y.4
Byun, H.-R.5
Kim, D.H.6
Kim, Y.-H.7
-
10
-
-
47249142795
-
Enhanced clearance of Ab in brain by sustaining the plasmin proteolysis cascade
-
Jacobsen JS, Comery TA, Martone RL, Elokdah H, Crandall DL, Oganesian A, Aschmies S, et al. Enhanced clearance of Ab in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci USA 2008;105:8754-9.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 8754-8759
-
-
Jacobsen, J.S.1
Comery, T.A.2
Martone, R.L.3
Elokdah, H.4
Crandall, D.L.5
Oganesian, A.6
Aschmies, S.7
-
11
-
-
79955954909
-
Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of alzheimer's disease
-
Liu R-M, Van Groen T, Katre A, Cao D, Kadisha I, Ballinger C, Wang L, et al. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging 2011;32:1079-89.
-
(2011)
Neurobiol Aging
, vol.32
, pp. 1079-1089
-
-
Liu, R.-M.1
Van Groen, T.2
Katre, A.3
Cao, D.4
Kadisha, I.5
Ballinger, C.6
Wang, L.7
-
12
-
-
14644407485
-
B-Amyloid (Ab) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation
-
Kranenburg O, Bouma B, Gent YYJ, Aarsman CJ, Kayed R, Posthuma G, Schiks B, et al. b-Amyloid (Ab) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation. Mol Cell Neurosci 2005;28: 496-508.
-
(2005)
Mol Cell Neurosci
, vol.28
, pp. 496-508
-
-
Kranenburg, O.1
Bouma, B.2
Yyj, G.3
Aarsman, C.J.4
Kayed, R.5
Posthuma, G.6
Schiks, B.7
-
13
-
-
0141641077
-
The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-b(Ab) degradation and inhibits Ab-induced neurodegeneration
-
Melchor JP, Pawlak R, Strickland S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-b(Ab) degradation and inhibits Ab-induced neurodegeneration. J Neurosci 2003;23:8867-71.
-
(2003)
J Neurosci
, vol.23
, pp. 8867-8871
-
-
Melchor, J.P.1
Pawlak, R.2
Strickland, S.3
-
14
-
-
34547131583
-
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms
-
Cacquevel M, Launay S, Castel H, Benchenane K, Chéenne S, Buée L, Moons L, et al. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol Dis 2007;27: 164-73.
-
(2007)
Neurobiol Dis
, vol.27
, pp. 164-173
-
-
Cacquevel, M.1
Launay, S.2
Castel, H.3
Benchenane, K.4
Chéenne, S.5
Buée, L.6
Moons, L.7
-
15
-
-
62649160992
-
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
-
Fabbro S, Seeds NW. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 2009;109:303-15.
-
(2009)
J Neurochem
, vol.109
, pp. 303-315
-
-
Fabbro, S.1
Seeds, N.W.2
-
16
-
-
18944389722
-
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation
-
Medina MG, Ledesma MD, Domínguez JE, Medina M, Zafra D, Alameda F, Dotti CG, et al. Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 2005;24:1706-16.
-
(2005)
EMBO J
, vol.24
, pp. 1706-1716
-
-
Medina, M.G.1
Ledesma, M.D.2
Domínguez, J.E.3
Medina, M.4
Zafra, D.5
Alameda, F.6
Dotti, C.G.7
-
17
-
-
0019866196
-
Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: A possible additional role for plasminogen activator?
-
Radcliffe R, Heinze T. Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator? Arch Biochem Biophys 1981;211: 750-61.
-
(1981)
Arch Biochem Biophys
, vol.211
, pp. 750-761
-
-
Radcliffe, R.1
Heinze, T.2
-
18
-
-
0031571604
-
Denatured proteins as cofactors for plasminogen activation
-
Machovich R, Owen WG. Denatured proteins as cofactors for plasminogen activation. Arch Biochem Biophys 1997;344:343-9.
-
(1997)
Arch Biochem Biophys
, vol.344
, pp. 343-349
-
-
MacHovich, R.1
Owen, W.G.2
-
19
-
-
31744446966
-
Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator
-
Galántai R, Módos K, Fidy J, Kolev K, Machovich R. Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator. Biochem Biophys Res Commun 2006;341:736-41.
-
(2006)
Biochem Biophys Res Commun
, vol.341
, pp. 736-741
-
-
Galántai, R.1
Módos, K.2
Fidy, J.3
Kolev, K.4
MacHovich, R.5
-
20
-
-
0022974681
-
On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid
-
Zonneveld AJ van, Veerman H, Pannekoek H. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid. J Biol Chem 1986;261:14214-8.
-
(1986)
J Biol Chem
, vol.261
, pp. 14214-14218
-
-
Van, Z.A.J.1
Veerman, H.2
Pannekoek, H.3
-
21
-
-
0024424509
-
Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin
-
Stein PL, Zonneveld AJ van, Pannekoek H, Strickland S. Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin. J Biol Chem 1989;264:15441-4.
-
(1989)
J Biol Chem
, vol.264
, pp. 15441-15444
-
-
Stein, P.L.1
Van, Z.A.J.2
Pannekoek, H.3
Strickland, S.4
-
22
-
-
54249150387
-
Identification of fibronectin type i domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs
-
Maas C, Schiks B, Strangi RD, Hackeng TM, Bouma BN, Gebbink MFBG, Bouma B. Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs. Amyloid 2008;15:166-80.
-
(2008)
Amyloid
, vol.15
, pp. 166-180
-
-
Maas, C.1
Schiks, B.2
Strangi, R.D.3
Hackeng, T.M.4
Bouma, B.N.5
Mfbg, G.6
Bouma, B.7
-
23
-
-
0344564905
-
Autonomous functions of structural domains on human tissue-type plasminogen activator
-
Zonneveld AJ van, Veerman H, Pannekoek H. Autonomous functions of structural domains on human tissue-type plasminogen activator. Proc Natl Acad Sci USA 1986;83:4670-4.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 4670-4674
-
-
Van, Z.A.J.1
Veerman, H.2
Pannekoek, H.3
-
24
-
-
0037168655
-
A structural model for Alzheimer's b-amyloid fibrils based on experimental constraints from solid state NMR
-
Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R. A structural model for Alzheimer's b-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002;99:16742-7.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 16742-16747
-
-
Petkova, A.T.1
Ishii, Y.2
Balbach, J.J.3
Antzutkin, O.N.4
Leapman, R.D.5
Delaglio, F.6
Tycko, R.7
-
25
-
-
28444442999
-
3D structure of Alzheimer's amyloid-b(1-42) fibrils
-
Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, Riek R. 3D structure of Alzheimer's amyloid-b(1-42) fibrils. Proc Natl Acad Sci USA 2005;102:17342-7.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 17342-17347
-
-
Lührs, T.1
Ritter, C.2
Adrian, M.3
Riek-Loher, D.4
Bohrmann, B.5
Döbeli, H.6
Riek, R.7
-
26
-
-
50049095633
-
Atomic structure of the cross-b spine of islet amyloid polypeptide (amylin)
-
Wiltzius JJW, Sievers SA, Sawaya MR, Cascio D, Popov D, Riekel C, Eisenberg D. Atomic structure of the cross-b spine of islet amyloid polypeptide (amylin). Protein Sci 2008;17:1467-74.
-
(2008)
Protein Sci
, vol.17
, pp. 1467-1474
-
-
Jjw, W.1
Sievers, S.A.2
Sawaya, M.R.3
Cascio, D.4
Popov, D.5
Riekel, C.6
Eisenberg, D.7
-
27
-
-
78650857643
-
Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions
-
Haupt C, Morgado I, Kumar ST, Parthier C, Bereza M, Hortschansky P, Stubbs MT, et al. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions. J Mol Biol 2011;405:341-8.
-
(2011)
J Mol Biol
, vol.405
, pp. 341-348
-
-
Haupt, C.1
Morgado, I.2
Kumar, S.T.3
Parthier, C.4
Bereza, M.5
Hortschansky, P.6
Stubbs, M.T.7
-
28
-
-
79953891845
-
Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils
-
Haupt C, Bereza M, Kumar ST, Kieninger B, Morgado I, Hortschansky P, Fritz G, et al. Pattern recognition with a fibril-specific antibody fragment reveals the surface variability of natural amyloid fibrils. J Mol Biol 2011;408:529-40.
-
(2011)
J Mol Biol
, vol.408
, pp. 529-540
-
-
Haupt, C.1
Bereza, M.2
Kumar, S.T.3
Kieninger, B.4
Morgado, I.5
Hortschansky, P.6
Fritz, G.7
-
29
-
-
0033522988
-
Endogenous proteins controlling amyloid b-peptide polymerization possible implications for b-amyloid formation in the central nervous system and in peripheral tissues
-
Bohrmann B, Tjernberg L, Kuner P, Poli S, Levet-Trafit B, Näslund J, Richards G, et al. Endogenous proteins controlling amyloid b-peptide polymerization possible implications for b-amyloid formation in the central nervous system and in peripheral tissues. J Biol Chem 1999;274:15990-5.
-
(1999)
J Biol Chem
, vol.274
, pp. 15990-15995
-
-
Bohrmann, B.1
Tjernberg, L.2
Kuner, P.3
Poli, S.4
Levet-Trafit, B.5
Näslund, J.6
Richards, G.7
-
30
-
-
1242338809
-
Co-accumulation of vascular endothelial growth factor with b-amyloid in the brain of patients with Alzheimer's disease
-
Yang S-P, Bae D-G, Kang HJ, Gwag BJ, Gho YS, Chae C-B. Co-accumulation of vascular endothelial growth factor with b-amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 2004;25:283-90.
-
(2004)
Neurobiol Aging
, vol.25
, pp. 283-290
-
-
Yang, S.-P.1
Bae, D.-G.2
Kang, H.J.3
Gwag, B.J.4
Gho, Y.S.5
Chae, C.-B.6
-
31
-
-
80051558232
-
Differential recognition of vascular and parenchymal beta amyloid deposition
-
Rutgers KS, Van Remoortere A, Van Buchem MA, Verrips CT, Greenberg SM, Bacskai BJ, Frosch MP, et al. Differential recognition of vascular and parenchymal beta amyloid deposition. Neurobiol Aging 2011;32:1774-83.
-
(2011)
Neurobiol Aging
, vol.32
, pp. 1774-1783
-
-
Rutgers, K.S.1
Van Remoortere, A.2
Van Buchem, M.A.3
Verrips, C.T.4
Greenberg, S.M.5
Bacskai, B.J.6
Frosch, M.P.7
-
32
-
-
0023054164
-
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin
-
Verheijen JH, Caspers MP, Chang GT, De Munk GA, Pouwels PH, Enger-Valk BE. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin. EMBO J 1986;5:3525-30.
-
(1986)
EMBO J
, vol.5
, pp. 3525-3530
-
-
Verheijen, J.H.1
Caspers, M.P.2
Chang, G.T.3
De Munk, G.A.4
Pouwels, P.H.5
Enger-Valk, B.E.6
-
33
-
-
0024078456
-
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain
-
Gething MJ, Adler B, Boose JA, Gerard RD, Madison EL, McGookey D, Meidell RS, et al. Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J 1988;7:2731-40.
-
(1988)
EMBO J
, vol.7
, pp. 2731-2740
-
-
Gething, M.J.1
Adler, B.2
Boose, J.A.3
Gerard, R.D.4
Madison, E.L.5
McGookey, D.6
Meidell, R.S.7
-
34
-
-
0025731989
-
High resolution analysis of functional determinants on human tissue-type plasminogen activator
-
Bennett WF, Paoni NF, Keyt BA, Botstein D, Jones AJ, Presta L, Wurm FM, et al. High resolution analysis of functional determinants on human tissue-type plasminogen activator. J Biol Chem 1991;266:5191-201.
-
(1991)
J Biol Chem
, vol.266
, pp. 5191-5201
-
-
Bennett, W.F.1
Paoni, N.F.2
Keyt, B.A.3
Botstein, D.4
Jones, A.J.5
Presta, L.6
Wurm, F.M.7
-
35
-
-
0029967088
-
Structure/function analysis of human factor XII using recombinant deletion mutants
-
Citarella F, Ravon DM, Pascucci B, Felici A, Fantoni A, Hack CE. Structure/function analysis of human factor XII using recombinant deletion mutants. Eur J Biochem 1996;238:240-9.
-
(1996)
Eur J Biochem
, vol.238
, pp. 240-249
-
-
Citarella, F.1
Ravon, D.M.2
Pascucci, B.3
Felici, A.4
Fantoni, A.5
Hack, C.E.6
|